We are live on ! Find out more
NVRO

NEVRO CORP.

Delisted

NVRO was delisted on the 2nd of April, 2025.

201 hedge funds and large institutions have $2.4B invested in NEVRO CORP. in 2017 Q2 according to their latest regulatory filings, with 50 funds opening new positions, 89 increasing their positions, 46 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

93% more repeat investments, than reductions

Existing positions increased: 89 | Existing positions reduced: 46

22% more first-time investments, than exits

New positions opened: 50 | Existing positions closed: 41

4% more funds holding

Funds holding: 193201 (+8)

14% less capital invested

Capital invested by funds: $2.8B → $2.4B (-$397M)

20% less funds holding in top 10

Funds holding in top 10: 54 (-1)

25% less call options, than puts

Call options by funds: $14.7M | Put options by funds: $19.6M

Holders
201
Holders Change
+8
Holders Change %
+4.15%
% of All Funds
5.01%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.1%
New
50
Increased
89
Reduced
46
Closed
41
Calls
$14.7M
Puts
$19.6M
Net Calls
-$4.91M
Net Calls Change
-$6.31M
Name Holding Trade Value Shares
Change
Change in
Stake
IWM
201
IHT Wealth Management
Illinois
$6 +$5.77K +72 New
Wellington Management Group
202
Wellington Management Group
Massachusetts
-$51.8M -552,452 Closed
1832 Asset Management
203
1832 Asset Management
Ontario, Canada
-$45.6M -497,700 Closed
Victory Capital Management
204
Victory Capital Management
Texas
-$26.8M -285,850 Closed
PA
205
Perceptive Advisors
New York
-$20.4M -217,292 Closed
NCGI
206
Next Century Growth Investors
Minnesota
-$20M -213,526 Closed
Loomis, Sayles & Company
207
Loomis, Sayles & Company
Massachusetts
-$16.4M -175,488 Closed
CM
208
Castleark Management
Illinois
-$15.1M -160,655 Closed
PHS
209
PFM Health Sciences
California
-$10.9M -116,836 Closed
ACM
210
Atika Capital Management
New York
-$6.3M -67,200 Closed
AII
211
AGF Investments Inc
Ontario, Canada
-$4.68M -50,000 Closed
FA
212
Friess Associates
Delaware
-$3.45M -36,792 Closed
Balyasny Asset Management
213
Balyasny Asset Management
Illinois
-$2.92M -36,400 Closed
Adage Capital Partners
214
Adage Capital Partners
Massachusetts
-$2.81M -30,000 Closed
PM
215
Precept Management
Texas
-$2.71M -28,900 Closed
OCM
216
Osterweis Capital Management
California
-$2.58M -27,519 Closed
TCM
217
Timpani Capital Management
Wisconsin
-$2.35M -25,051 Closed
CPIM
218
Columbia Partners Investment Management
Virginia
-$2.21M -23,561 Closed
PC
219
Polar Capital
United Kingdom
-$1.84M -19,596 Closed
HSBC Holdings
220
HSBC Holdings
United Kingdom
-$1.68M -17,503 Closed
TA
221
Tamarack Advisers
California
-$1.6M -17,100 Closed
DCM
222
Driehaus Capital Management
Illinois
-$968K -10,332 Closed
GAM
223
Gotham Asset Management
New York
-$931K -9,939 Closed
PP
224
Paloma Partners
Connecticut
-$931K -9,937 Closed
SI
225
Shaker Investments
Ohio
-$796K -8,500 Closed

NVRO Hedge Fund Activity: Q2 2017 in Review

201 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in NEVRO CORP. (NVRO) for Q2 2017, worth a combined $2.4B — down 14% from $2.8B a quarter earlier.

Buyers outnumbered sellers: 50 funds opened new NVRO positions and 41 closed out — a net gain of 9 holders — while 89 added to existing stakes and 46 trimmed.

The largest buyer was Janus Henderson Group, opening a new position worth an estimated $114M. The largest seller was Fidelity Investments, cutting an estimated $78.3M.

  • 201 institutional investors held NEVRO CORP. (NVRO) as of Q2 2017, up from 193 in Q1 2017.
  • Funds reported $2.4B of NEVRO CORP. stock for Q2 2017, down 14% quarter-over-quarter.
  • 50 funds opened new NEVRO CORP. positions in Q2 2017 and 41 closed out, a net change of +9 holders.
  • The largest NEVRO CORP. buyer in Q2 2017 was Janus Henderson Group, an estimated $114M added.
  • The largest NEVRO CORP. seller in Q2 2017 was Fidelity Investments, an estimated $78.3M sold.

Based on aggregated 13F filings for Q2 2017.